Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04751929
Title Abemaciclib With or Without Atezolizumab for mCRPC
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST